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Abstract
Theiler murine encephalomyelitis virus (TMEV), DA strain, induces in susceptible strain of mice a biphasic disease consisting of early
acute disease followed by late chronic demyelinating disease. Both phases of the disease are associated with inflammatory infiltrates of the
central nervous system (CNS). Late chronic demyelinating disease induced by TMEV serves as an excellent model to study human
demyelinating disease, multiple sclerosis. During early acute disease, the virus is partially cleared from the CNS by CD3 T cells. These
T cells express Fas, FasL, negligible levels of Bcl-2 proteins and undergo activation-induced cell death as determined by TUNEL assay
leading to resolution of the inflammatory response. In contrast, during late chronic demyelinating disease, and despite dense perivascular
and leptomeningeal infiltrates, only very few cells undergo apoptosis. Mononuclear cells infiltrating the CNS express Bcl-2. It appears that
the lack of apoptosis of T cells during late chronic demyelinating disease leads to the accumulation of these cells in the CNS. These cells
may play a role in the pathogenesis of the demyelinating disease.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Theiler murine encephalomyelitis virus (TMEV), a pi-
coma virus, induces in susceptible strains of mice, such as
SJL, biphasic disease, consisting of early acute disease and
late chronic demyelinating disease (Oleszak et al., in press;
Oleszak et al., 1995; Rodriguez et al., 1987; Theiler, 1937;
Tsunoda and Fujinami, 1996). During early acute disease,
the virus replicates in the gray matter of the brain predom-
inantly in the neurons, but also in astrocytes, microglia/
macrophages, and oligodendrocytes (Brahic et al., 1981;
Levy et al., 1992; Lipton, 1975; Rodriguez et al., 1987).
After early acute disease-resistant strains of mice, such as
C57BL/6 (B6), clear the infection in contrast susceptible
strains, such as SJL, develop chronic, inflammatory demy-
elinating disease associated with a low level of viral persis-
tence mainly in macrophages, astrocytes, and oligodendro-
cytes (Brahic et al., 1981; Rodriguez et al., 1987; Theiler,
1937). This disease closely resembles multiple sclerosis
(MS). Both phases of the disease are associated with
perivascular and parenchymal inflammatory infiltrates com-
prising T cells, monocytes/macrophages, and some B cells
(Dal Canto et al., 1996; Oleszak et al., in press; Oleszak et
al., 1995; Tsunoda and Fujinami, 1996). Although both
CD4 and CD8 T cells contribute to the clearance of the
virus, lack of complete clearance has been attributed to low
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level and late appearance of virus-specific cytotoxic T lym-
phocytes (CTL) (Dethlefs et al., 1997; Larsson-Sciard et al.,
1997). Myelin damage during late chronic demyelinating
disease is thought to be immunologically mediated and both
CD4 and CD8 T cells may contribute to the process
(Azoulay-Cayla et al., 2000; Inoue et al., 1999; Kang et al.,
2000; Katz-Levy et al., 2000; Kim et al., 1999; Murray et
al., 1998; Rivera-Quinones et al., 1998). Thus, T cells play
a very important role in TMEV-induced disease, participat-
ing both in the clearance of the virus and in the damage of
myelin.
Apoptosis regulates virus-induced T cell responses, im-
mune suppression, appearance of memory T cells, and sur-
vival of target cells and it is essential for maintaining ho-
meostasis in the immune system (Alcami and Koszinowski,
2000; Antia et al., 1998; Butz and Bevan, 1998; Grayson et
al., 2000; Lenardo, 1996; Marten et al., 2000; Murali-
Krishna et al., 1998; Van Parijs and Abbas, 1998). It is well
established that acute infections with a number of viruses
including lymphocytic choriomeningitis (LCMV), human
immunodeficiency virus (HIV), measles virus, Epstein–Barr
virus (EBV), and a number of others lead to 5- to 50-fold
increase in virus-specific T cells, which eliminate the virus-
infected cells, clearing the virus (Blattman et al., 2000; Butz
and Bevan, 1998; Doherty and Christensen, 2000; Kottilil et
al., 2000; Maini et al., 2000; Mongkolsapaya et al., 1999;
Murali-Krishna et al., 1998). After elimination of the virus,
there is a decline in T cell numbers through the apoptotic
mechanism of activation-induced cell death (AICD), which
involves T cell receptor (TCR) activation (Bossu et al.,
1993; Green and Scott, 1994; Russell, 1995; Singer and
Abbas, 1994). Activated T cells produce potentially hazard-
ous molecules, such as TNF-, IL-1, perforin, and gran-
zymes. AICD is necessary to silence this massive immune/
inflammatory response after clearance of the virus (Ahmed
and Gray, 1996; Akbar and Salmon, 1997; Akbar et al.,
1994; Matloubian et al., 1999; Swain et al., 1996). Thus, the
expansion of T lymphocytes after the immune response to
the virus during early acute disease is followed by elimina-
tion of these cells by apoptosis. Only a small proportion of
virus-specific T cells survive, to become memory cells (re-
viewed by Ahmed and Gray, 1996; Swain et al., 1996).
AICD is mediated by the Fas (CD95)/FasL (CD95L) and
TNF-receptor type I (TNF-RI) pathways, both of which
share a common cell death domain (Brunner et al., 1995;
Dhein et al., 1995; Strasser et al., 1995; Swain et al., 1996;
Zheng et al., 1995). Fas belongs to the TNF/nerve growth
factor receptor family; it is ubiquitously expressed on lym-
phoid cells and is significantly induced following activation
of T cells (for review see Wallach et al., 1998). FasL
belongs to the TNF family and is expressed constitutively
only in immune-privileged sites, such as eyes or testes
levels on naive T cells, but its expression is significantly
upregulated following T cell activation (Beutler and van
Huffel, 1994; Brunner et al., 1995; Cohen and Eisenberg,
1991; Dhein et al., 1995). Activation of the Fas/FasL path-
way results in induction of a specific death-inducing signal-
ing complex (DISC), which triggers the sequential activa-
tion of caspases (reviewed in Budihardjo et al., 1999). On
the cellular level, activation of Fas/FasL on T cells through
TCR leads to apoptotic cell death characterized by DNA
fragmentation, chromatin condensation, and cytoplasmic
shrinkage with preservation of membrane integrity (Odaka
et al., 1990; Wyllie et al., 1984). Fas-mediated death is
regulated by a number of molecules, including Bcl-2, a
protooncogene, which is expressed on the mitochondrial
outer membrane and protects cells against many mecha-
nisms of cell death (reviewed by Chao and Korsmeyer,
1998).
Cytokines also play an important role in regulating apop-
totic cell death of T cells (reviewed by Lenardo et al., 1999).
IL-2 is a particularly important cytokine, because, while it
predisposes T cells to apoptosis, it also prevents apoptosis
of activated T cells through upregulation of Bcl-2 (Refaeli
et al., 1998; Van Parijs et al., 1999). Thus, virus-induced T
cell responses are tightly regulated by the Fas/FasL path-
way, members of Bcl-2 family, and cytokines. The impor-
tance of Fas-mediated apoptosis in controlling homeostasis
of the immune response has been demonstrated in both mice
and humans. Mice or humans with genetically defective Fas
or FasL develop systemic autoimmunity, leading to such
diseases as Hashimoto thyroiditis in humans and autoim-
mune diabetes in nonobese diabetic mice, as well as other
diseases (Chervonsky et al., 1997; Cohen and Eisenberg,
1991; Giordano et al., 1997). Tsunoda et al. (1997) have
shown that during early acute disease neurons from TMEV-
infected mice are the predominant cell types that undergo
apoptosis. However, during late chronic demyelinating dis-
ease, cells stained with antibodies to carbonic anhydrase
(presumably, oligodendrocytes) and macrophages showed
apoptotic features (Tsunoda et al., 1997). In vitro studies
using the GDVII strain of TMEV, which induces only gray
matter disease, revealed that this virus induces apoptosis in
restrictive but not in permissive cells (Jelachich and Lipton,
1996). However, the fate of the central nervous system
(CNS)-infiltrating T cells in TMEV-infected mice has not
been examined.
The purpose of this study has been to determine the fate
of inflammatory infiltrating cells in the CNS of TMEV-
infected mice during early acute and late chronic demyeli-
nating disease. We have also examined the expression of
molecules participating in Fas/FasL-induced cell death, an-
tiapoptotic genes such as Bcl-2, and certain cytokines.
Results
Apoptosis in the CNS of TMEV-infected mice
Histopathological examination of the CNS of TMEV-
infected SJL mice, which are susceptible to TMEV-induced
demyelination, at various time intervals postinfection (p.i.)
111E.L. Oleszak et al. / Virology 315 (2003) 110–123
(3, 6, 10, 42, 62, 107, and 170 days p.i.) revealed a typical
biphasic disease comprising early acute disease that resem-
bles polioencephalomyelitis followed by late chronic demy-
elinating disease. In contrast, B6 mice, which are resistant to
TMEV-induced demyelinating disease, developed only
early acute disease and cleared the virus without developing
subsequently late chronic demyelinating disease. These his-
topathological results are typical of those previously re-
ported by ourselves (Chang et al., 2000; Oleszak et al.,
1988, 1995, 1997), and others (reviewed by Dal Canto et al.,
1996; Monteyne et al., 1997; Tsunoda and Fujinami, 1996).
In this study, we investigated whether apoptotic cell death
occurs in the CNS of TMEV-infected mice during early
acute disease and late chronic demyelinating disease.
Apoptosis during early acute disease
At 3 days p.i. very few infiltrating mononuclear cells were
detected in the CNS of TMEV-infected SJL and B6 mice.
None of them were apoptotic (data not shown). However, the
titer of the virus in the CNS of TMEV-infected SJL mice
reached maximum levels at 3 days p.i. (1.3 106 PFU/g) and
it was reduced by approximately 3 logs (5 102 PFU/g) at 10
days p.i. At 6, 7, and 10 days p.i. a brisk inflammatory response
with microscopic foci of brain tissue necrosis was present in
the CNS of TMEV-infected SJL mice (focally necrotizing
encephalitis). It consisted of inflammatory infiltrates of mono-
nuclear cells (MNC) involving predominantly the regions of
the basal ganglia and thalamus and exhibiting a distinctive
perivascular topographic predilection. A noteworthy number
of MNC particularly in perivascular cuffs (and also in the
intervening neuropil) were TUNEL (Figs. 1A–C). At 6 days
p.i. there were no differences in the extent and distribution of
TUNEL  MNC between TMEV-infected SJL and B6 mice
(data not shown). By light microscopy, TUNEL cells were
morphologically suggestive of apoptotic cells (characterized
by chromatin condensation and cellular shrinkage). TUNEL
staining of CNS tissue from TMEV-infected SJL mice showed
that cells undergoing apoptosis were located predominantly in
perivascular cuffs. Fig. 1B shows a higher magnification of a
blood vessel in the basal ganglia (7 days p.i.), demonstrating
dense perivascular cuffing of lymphocytes and to a lesser
degree monocytes. Several TUNEL apoptotic cells were
predominately lymphocytes, some of which were engulfed
within the cytoplasm of monocytes/macrophages.
To identify the cell types undergoing apoptosis, brain
tissue sections immediately adjacent to tissue shown in Fig.
1B have been double-labeled for CD3 T cells and for
TUNEL cells. TUNEL cells stained brown (DAB),
whereas CD3-positive cells show a purple membrane/cyto-
plasmic staining (VIP) (Fig. 1C). Apoptotic cells identified
within the perivascular cuffs were predominantly CD3 T
cells (Fig. 1C). Fig. 1 shows the topographical relationships
of these mononuclear inflammatory cells during early acute
disease. It should be noted that the bulk of inflammatory
cells (predominantly CD3 T lymphocytes) undergoing
apoptosis is concentrated in the leptomeninges and in the
perivascular (Virchow-Robbin spaces) of the CNS paren-
chyma. Figs. 1B, E, and F depict unequivocal containment
of TUNEL lymphocytes in the cytoplasm of larger cells
situated at the rim of the perivascular inflammatory cuffs,
which exhibit overt, unambiguous morphological features
of monocytes/macrophages.
Immunohistochemical staining using a TMEV-specific
monoclonal antibody (mAb) revealed robust cytoplasmic
staining of presumptive macrophages within an area of acute
encephalitis at 7 days p.i. (Fig. 1D, left). The same anti-TMEV
mAb stained a number of cells presumably infected with
TMEV (data not shown), as described (Tsunoda et al., 1997).
No evidence of staining with the anti-TMEV antibody was
observed (Fig. 1D, right) in a deeper section of the same blood
vessel as in Fig. 1B (1000). This suggests that the primary
role of macrophages in the perivascular cuffs is to remove
apoptotic T cells and not to serve as a viral reservoir. Light
background staining of endothelial cells is not specific and has
been observed in tissue stained with control antibodies (data
not shown).
TUNEL staining of CNS tissue from TMEV-infected SJL
mice showed that cells undergoing apoptosis were located
predominantly in perivascular cuffs. In addition, a number of
TUNEL neurons (Fig. 1E) or macrophages (Fig. 1F) were
detected in the CNS in areas of active encephalitis at days 3, 6,
and 10 p.i. in TMEV-infected SJL or B6 mice. TUNEL
neurons in areas of necrotizing encephalitis do not show an
apoptotic morphology. It is possible that the TUNEL neu-
rons are undergoing incipient necrosis (Fig. 1E). Apoptosis
involving predominantly lymphocytes (l), and to lesser extent
macrophage/microglia (m), were identified in the neuropil of
the basal ganglia away from perivascular cuffs (Fig. 1F). This
process ultimately leads to resolution of the inflammatory
cuffs. Few TMEV-infected macrophages infiltrating paren-
chyma were also TUNEL, in agreement with the findings of
Tsunoda et al. (1997).
Apoptosis during late chronic demyelinating disease:
immunohistochemical analysis
This phase of the disease is associated with spinal cord
parenchymal (intramedullary) demyelinating lesions and
heavy leptomeningeal and perivascular infiltration of MNC.
Fig. 2 (as well as Fig. 1, see above) shows the topographical
relationships of the infiltrating mononuclear inflammatory
cells during TMEV-induced disease. Quantitative compari-
son of TUNEL CD3 cells between early acute disease
(brain) and late chronic demyelinating disease (spinal cord)
is shown in Fig. 3 and has been carried out by double
staining determinations for CD3 cells and ex vivo
TUNEL cells using flow cytometry.
In contrast to early acute disease induced by TMEV (Fig.
1), very few TUNEL MNC (presumptive apoptotic lym-
phocytes) were detected in the spinal cord of TMEV-in-
fected SJL mice at 42 days p.i. (Fig. 2A), 62 days p.i. (Fig.
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2B), 107 days p.i. (Fig. 2C), and 170 days p.i. (Fig. 2D).
Few cells (dark stain) present outside of the perivascular
cuff in Fig. 2B represent cells of the monocyte/macrophage
lineage or oligodendrocytes. In contrast, inflammatory
MNC within perivascular cuffs are not TUNEL positive.
Numerous apoptotic cells, present in the upper corner of
Fig. 2C, are cells of bone marrow of vertebral spine adjacent
to spinal cord. Cells of bone marrow are continuously un-
dergoing apoptosis and this is a normal physiological pro-
cess. In contrast, very few cells in perivascular cuffs present
in Fig. 2A to D are undergoing apoptosis.
Quantitative analysis by flow cytometry of mononuclear
cells undergoing apoptosis in the CNS of TMEV-infected
mice during early acute and late chronic demyelinating
disease employing ex vivo TUNEL assay combined with
anti-CD3 staining
Quantitative analysis of apoptosis of CD3 T cells infil-
trating the CNS of TMEV-infected mice was carried out by
Fig. 1. Apoptosis in the brain of TMEV-infected SJL mice during the enceph-
alitic phase of the disease. (A) Staining was performed on paraffin-embedded
brain tissue, 6 days p.i., using the TUNEL method and DAB as the immuno-
peroxidase chromogen. Florid deep gray matter inflammation involving the
basal ganglia is observed. Perivascular mononuclear cell infiltrates (arrow-
heads) egress into the surrounding brain substance. Increased TUNEL local-
ization is restricted to areas of inflammation. No evidence of apoptosis in
neurons of the nearby unaffected hippocampus (h), 100. (B) High magnifi-
cation of a blood vessel in the basal ganglia (7 days p.i.) showing dense
perivascular cuffing of lymphocytes and to a lesser degree of monocyte/
macrophages. Several TUNEL apoptotic cells are predominantly lympho-
cytes, some of which are engulfed within the cytoplasm of macrophages
(arrowheads), 1000. (C) Colocalization of TUNEL and CD3 cells in
inflammatory mononuclear cells in the brain of TMEV-infected SJL mice at 7
days p.i. Double immunoperoxidase staining of perivascular infiltrates using
TUNEL and anti-CD3 monoclonal antibody. TUNEL cells appear brown
(DAB substrate; arrows), whereas CD3 T cells show a purple membranous/
cytoplasmic staining using VIP substrate (arrowheads). Numerous TUNEL
apoptotic mononuclear cells are morphologically similar to the adjoining
CD3 T lymphocytes, 1000. (D) Robust cytoplasmic staining with anti-
TMEV antibody of presumptive macrophages within an area of acute enceph-
alitis at 7 days p.i. (left), and no evidence of staining with anti-TMEV antibody
(right) in a deeper section of the same blood vessel as in B, 1000. Light
brown staining of endothelial cells is not specific and has been observed in
tissue slides stained with control antibodies (not shown). (E) 7 days p.i.
showing TUNEL localization in a rare neuron in a field of inflammation
(asterisk) and in a lymphocyte within the cytoplasm of a macrophage (arrow-
head), 400. (F) A nearby field in the basal ganglia showing apoptosis
involving predominantly lymphocytes (l), and to lesser extent macrophage/
microglia (m), 400. Fig. 2. Paucity of apoptosis during late chronic demyelinating disease in
TMEV-infected SJL mice (spinal cords) at 42 days p.i. (A), 62 days p.i.
(B), 107 days p.i. (C), and 170 days p.i. (D). Despite the presence of heavy
perivascular and leptomeningeal infiltrates, only rare apoptotic mononu-
clear inflammatory cells are identified. Arrowheads depict aggregates
(cuffs) of perivascular inflammatory cells (A, B, C, D). There are only rare
TUNEL cells outside the perivascular cuffs, which may represent cells of
monocyte/macrophage lineage or oligodendrocytes (arrows) (B). Inset in C
is a higher magnification of one of the cellular cuffs showing paucity of
TUNEL staining in inflammatory cuffs. Note the presence of numerous
TUNEL cells within the bone marrow (BM) of the vertebral spine at the
corresponding level of the spinal cord (Fig. 2C). Original magnifications
(A, B, and C) 100 [inset in C, 400], and D, 400.
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flow cytometry in double staining experiments employing
ex vivo TUNEL assay combined with CD3 T cell sur-
face staining. To assure that all T cells (present in
perivascular cuffs, parenchyma, and meninges of TMEV-
infected mice) are included in the determination, we
isolated mononuclear cells from the CNS of TMEV-
infected mice using Percoll gradients, as described under
Materials and methods. Staining for CD3 TUNEL
cells was carried out as described under Materials and
methods. For the ex vivo TUNEL staining FITC-
conjugated dUTP was used. For staining of CD3 T cells
PerCP-anti-CD3 mAb was employed. Results from four
experiments of double immunofluorescence staining of
CD3 TUNEL cells is shown in Fig. 3. Two of the
experiments shown are from early acute disease; the
remaining two are from late chronic demyelinating dis-
ease. Each data point was obtained using pooled cells
from the CNS of five to seven TMEV-infected mice.
Cells were first gated for CD3 T cells. During early
acute disease, at 7 and at 8 days p.i. 32.1 and 23.1% of
the CD3 cells, respectively, were undergoing apoptosis
(CD3 TUNEL). In contrast, during late chronic de-
myelinating disease, at 55 and at 189 days p.i. 5.8 and
1.6% of the CD3 cells, respectively, were undergoing
apoptosis (CD3 TUNEL). Statistical analysis (five
independent experiments) was carried out as described
under Materials and methods. The differences obtained in
the CD3 TUNEL fractions between early acute dis-
ease and late chronic demyelinating disease were signif-
icant (P  0.0311).
Fig. 7. Immunohistochemical detection of Bcl-2 in the CNS of TMEV-infected SJL mice at (A) 7 days p.i. (brain), (B) 40 days p.i. (spinal cord), (C) 107
days p.i. (spinal cord), and (D) 170 days p.i. (spinal cord). Staining was performed on 5 M paraffin-embedded sections with ABC immunoperoxidase (DAB)
method with hematoxylin counterstaining. (A) Early acute disease (encephalitic phase): lack of Bcl-2 expression in mononuclear inflammatory cell infiltrates
in perivascular cuff in the thalamic region, 1000. (B) Late chronic demyelinating disease (demyelinating phase): Bcl-2 expression in mononuclear
inflammatory cells in the subarachnoid space overlying an area of demyelination,400. (C and D) Late chronic demyelinating disease (demyelinating phase):
widespread localization of Bcl-2 in densely aggregated perivascular mononuclear inflammatory cells in the leptomeninges of the spinal cord observed at 107
and 170 days p.i., respectively. C: 400; D: 1000. Although these immunohistological preparations (A to D) were examined at different magnifications,
identical results were obtained in each panel.
Fig. 3. Apoptosis of CD3 T cells infiltrating the CNS of TMEV-infected
mice determined during early acute disease (brain; at 7 and 8 days p.i.) and
at late chronic demyelinating disease (spinal cord at 55 and 189 days p.i.).
Apoptosis (CD3 TUNEL cells) was measured by ex vivo TUNEL
assay. Mononuclear cells were isolated from either the brain or the spinal
cord, as described under Materials and methods. Cells were first labeled
with PerCP-conjugated anti-CD3 mAb, followed by staining with termi-
nal deoxynucleotidyl transferase (TdT) and FITC-dUTP (ex vivo TUNEL
assay), as described under Materials and methods. Samples were analyzed
by flow cytometry. Unshaded histograms represent fluorescence intensity
of TUNEL cells electronically gated on the CD3 T cell population.
Shaded histograms show fluorescence intensity of control samples, where
TdT was omitted, electronically gated on the CD3 T cell population.
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Expression of Fas and FasL in the CNS of TMEV-infected
mice during early acute and late chronic demyelinating
disease
The Fas/FasL (CD95/CD95L) pathway has been impli-
cated in AICD of clonally expanded T cells. Using flow
cytometric analysis low levels of Fas CD3 (5.4%) and
FasL CD3 (5.7%) cells were found in the spleen of
mock-infected SJL mice at 6 days p.i. Similar levels of
Fas CD3 and FasL CD3 cells have been reported by
others in the spleen of SJL mice using the same mAbs (Gao
et al, 2001).
Expression of Fas CD3 and FasL CD3 cells in the
spleen of TMEV-infected SJL mice at 6 days p.i. was 3.0 and
2.9%, respectively (Fig. 4). At 85 days p.i., the proportions of
Fas CD3 and FasL CD3 cells in the spleen of TMEV-
infected SJL mice were 6.8 and 5.8%, respectively (Fig. 4).
Statistical analysis of five independent determinations revealed
that there were no significant differences in the expression of
Fas CD3 cells in spleens of TMEV-infected SJL mice
during early acute vs late chronic demyelinating disease (P 
0.2116). Statistical analysis of four independent determinations
revealed that there were no significant differences in the ex-
pression of FasL CD3 cells (P  0.5203) in the spleens of
TMEV-infected SJL mice during early acute vs late chronic
demyelinating disease.
In contrast, expression of Fas CD3 and FasL CD3
cells was much higher in the brain than the spleen of
TMEV-infected SJL mice. At 6 days p.i. 40.6 to 48% of the
inflammatory infiltrates were CD3 T cells. Fas CD3
cells accounted for 24% of the brain infiltrating CD3 T
cells at 6 days p.i. (Fig. 5) and for 21% at 7 days p.i. FasL
CD3 cells accounted for 9% of the brain infiltrating CD3
T cells at 6 days p.i. (Fig. 5) and for 19% at 7 days p.i.
Representative results are shown in Fig. 5. Expression of
Fas and FasL on CD3 T cells suggests T cell receptor
engagement resulting likely in triggering of AICD of infil-
trating T cells during early acute disease.
We have also examined the expression of Fas and FasL
antigens on T cells infiltrating the spinal cord during late
chronic demyelinating disease. At 85 days p.i. 13 to 15% of
the mononuclear inflammatory infiltrates in the spinal cord
were CD3. The proportions of Fas CD3 T cells infil-
Fig. 5. Expression of Fas and FasL on CD3 T cells infiltrating the CNS
of TMEV-infected SJL mice at 6 (brain) and 85 (spinal cord) days p.i.
using flow cytometry. The fluorescence intensity was recorded in the log
mode. The percentages of CD3, Fas, and FasL, and double-positive
cells CD3/Fas and CD3/FasL in total inflammatory infiltrate are
given in each panel. Numbers in parentheses indicate percentages of
double-positive cells as a proportion of CD3 T cells only. For details, see
legend to Fig. 4. Representative FSC and SSC patterns, including the
lymphocyte gate used for the analysis, is shown for both time points at the
bottom of Fig. 5.
Fig. 4. Expression of Fas and FasL on CD3 T cells in spleen of TMEV-
infected mice at 6 and 85 days p.i. using flow cytometry. Cells were first
labeled individually with PE-conjugated anti-CD3 antibodies, washed, and
then labeled with purified monoclonal antibodies to either Fas or FasL,
followed by labeling with biotinylated secondary antibodies FITC-conju-
gated as described under Materials and methods. The fluorescence intensity
was recorded in the log mode. Numbers in brackets indicate percentages of
double-positive cells as a proportion of CD3 T cells only.
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trating the spinal cord were examined at 85 (Fig. 5), 102,
and 142 days p.i. and were 21.6 (Fig. 5), 12.8 and 9%,
respectively. Statistical analysis of five independent deter-
minations revealed significant differences (P  0.0088) in
the expression of Fas CD3 cells in the brain of TMEV-
infected SJL mice during early acute disease vs the spinal
cord of these mice during late chronic demyelinating dis-
ease. The proportions of FasL CD3 T cells infiltrating
the spinal cord during late chronic demyelinating disease
were determined at 85 (Fig. 5) and 100 days p.i. and were
19.7 (Fig. 5) and 20%, respectively. Statistical analysis of
four independent determinations revealed no significant dif-
ferences (P  0.1039) in the expression of FasL CD3
cells in the brain of TMEV-infected SJL mice during early
acute disease vs the spinal cord during late chronic demy-
elinating disease.
Expression of Bcl-2 in the CNS of TMEV-infected SJL mice
during early acute and late chronic demyelinating disease
Flow cytometric analysis of Bcl-2 expression on CD3 T
cells infiltrating the brain of TMEV-infected SJL mice dur-
ing early acute disease at 8 days p.i. revealed negligible
levels of expression of this antiapoptotic gene (range 0.7–
1.3%) (Table 1 and Fig. 6 ). In contrast to negligible levels
of Bcl-2 expression on T cells infiltrating the brain of
TMEV-infected mice during early acute disease, CD3
Bcl-2 cells accounted for 9.8% of the CD3 T cells in the
spinal cord of TMEV-infected SJL mice before onset of
demyelinating disease at 33 days p.i., 21.5% of CD3 T
cells in the spinal cord of TMEV-infected SJL mice during
late chronic demyelinating disease at 100 days p.i., 24.4%
of CD3 T cells at 101 days p.i., 52.9% of CD3 T cells at
140 days p.i., 53% of CD3 T cells at 142 days p.i., and
32.5% of CD3 T cells at 145 days p.i. (Table 1 and Fig. 6).
Statistical analysis was carried out as described under Ma-
terials and methods and revealed significant differences in
the expression of CD3 Bcl-2 cells in the brain of TMEV-
infected SJL mice during early acute disease vs the spinal
cord of these mice during late chronic demyelinating dis-
ease (P  0.0099) (Table 1).
Analysis of T cells in the spleen of TMEV-infected mice
at 8 days p.i. revealed that CD3 Bcl-2 cells accounted
for 11% of CD3 T cells (Table 1), which is 10 times higher
than that of the proportions (1%) of CD3 Bcl-2 cells in
the brain of TMEV-infected mice at 8 days p.i. These results
suggest that the CD3 T cells, which infiltrate the brain of
TMEV-infected SJL mice at 8 days p.i., either downregulate
the expression of Bcl-2 or that the only T cells that are able
to migrate to the brain are those which express minimal
levels of Bcl-2. In either case, expression of Fas CD3
and FasL CD3 T cells and virtual absence of Bcl-2 on
these cells may account for efficient elimination of infiltrat-
ing T cells by AICD from the brain of TMEV-infected SJL
mice after viral clearance. These results support the hypoth-
esis that viral clearance in TMEV-infected SJL mice is
followed by downsizing of the inflammatory response
through AICD. The proportions of CD3 Bcl-2 cells in
the spleen of TMEV-infected mice during late chronic de-
myelinating disease were 12.2% at 100 days p.i., 39.7% at
142 days p.i., and 38.1% at 145 days p.i. (Table 1).
Table 1
Expression of Bcl-2 on CD3 T cells in the CNS and spleen of
TMEV-infected and mock-infected SJL mice
dpi Percentage of CD3 Bcl-2 cells (%)
TMEV CNS TMEV spleen Mock spleen
Early acute diseasea
8b 1.3 11.04 18.5
8b 0.7
Before onset of demyelinating disease
33c 9.8 ND ND
Late chronic demyelinating diseasea
100c 21.54 12.23 20.18
101c 24.4 ND ND
140c 52.9 ND ND
142c 53.0 39.7 22.0
145c 32.5 38.1 ND
Note. SJL mice were TMEV-infected or mock-infected as described
under Materials and methods. At the indicated times p.i. mice were per-
fused with PBS and mononuclear cells were isolated from the CNS (either
brain or spinal cord) and spleen as described under Materials and methods.
Mononuclear cells were double labeled with PerCP-conjugated anti-CD3
mAb and FITC-conjugated anti-Bcl-2 mAb and analyzed by flow cytom-
etry as described. ND, not done.
a Early vs late disease P  0.0099.
b Brain of TMEV-infected mice.
c Spinal cord of TMEV-infected mice.
Fig. 6. Expression of Bcl-2 on CD3 T cells infiltrating the CNS of
TMEV-infected SJL mice at 8 (brain) and 145 (spinal cord) days p.i.
Infiltrating mononuclear cells were isolated from the CNS, labeled with
PE-conjugated anti-CD3 mAb, permeabilized, stained with FITC-conju-
gated anti-Bcl-2 mAb, and analyzed by flow cytometry, as described under
Materials and methods. Unshaded histograms show fluorescence intensity
of Bcl-2 expressing cells electronically gated on the CD3-positive popu-
lation. Shaded histograms show fluorescence intensity of cells stained with
the isotype control of the anti-Bcl-2 mAb, electronically gated on the
CD3-positive population. The percentage of double-stained (CD3 Bcl-
2) cells in inflammatory infiltrates are indicated.
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Expression of Bcl-2 on CD3 T cells isolated from the
spleen of mock-infected SJL mice is shown in Table 1.
There were no statistically significant differences (P 
0.1439) in the expression of CD3 Bcl-2 cells in the
spleen of mock-infected SJL mice at 8 days p.i. (18.5%) vs
100 days p.i. (20.2%) and 142 days p.i. (22%).
Immunohistochemical staining confirmed lack of expres-
sion of Bcl-2 in inflammatory brain cuffs during early acute
disease (Fig. 7A). There are no positive cells in Fig. 7A. In
contrast, high expression of Bcl-2 in perivascular mononu-
clear inflammatory cells was evident in the spinal cord
during late chronic demyelinating disease, at 40 (Fig. 7B),
107 (Fig. 7C), and 170 (Fig. 7D) days p.i. Three-color flow
cytometric analysis of the inflammatory infiltrate isolated
from the spinal cord of TMEV-infected mice (CD3, Fas,
and Bcl-2) demonstrated that indeed at 142 days p.i. ap-
proximately 50% of double-positive CD3 Bcl-2 cells
also expressed Fas. (Fig. 8).
We have also examined the expression of Bcl-2 in mac-
rophages infiltrating the spinal cord of TMEV-infected SJL
mice. Although Mac-1-positive cells constitute only 8.5%
of the total infiltrate of the spinal cord during late chronic
demyelinating disease, approximately 40% of Mac-1-posi-
tive macrophages in the spinal cord expressed Bcl-2 (data
not shown). This finding may account for the low number of
macrophages undergoing apoptosis during late chronic de-
myelinating disease in our studies.
Discussion
The objective of this study has been to determine the fate
of CNS-infiltrating mononuclear cells in TMEV-infected
mice. We have demonstrated that during TMEV-induced
early acute disease infiltrating T cells are eliminated from
the CNS through AICD. This process follows the clearance
of the virus from the CNS of infected mice. In SJL mice the
virus titer dropped from approximately 1.3  106 PFU/g of
tissue on day 3 p.i., to 5 102 PFU/g of tissue on day 10 p.i.
In the CNS of B6 mice the virus titer reduced to almost
undetectable levels 10 days p.i. (data not shown). Double
labeling experiments, using TUNEL and anti-CD3 mAb
staining, demonstrated that the majority of the cells under-
going apoptosis were CD3 T cells, and that they were
located mainly in the perivascular cuffs in areas of enceph-
alitis. By 20 days p.i. the mononuclear cells disappear com-
pletely from the CNS of both strains of mice. Previous
reports suggested that neurons (ex vivo) and macrophages
(in vitro) infected with two different stains of TMEV un-
dergo apoptotic cell death (Jelachich and Lipton, 1996;
Kang et al., 2000; Kim and Palma, 1999; Tsunoda et al,
1997). However, apoptosis of mononuclear cells infiltrating
the CNS of TMEV-infected mice was not examined by
these investigators. In agreement with the reports of
Jelachich and Lipton (1996) and Tsunoda et al. (1997), we
also observed that the few cells other than infiltrating mono-
nuclear cells which stained positively in the TUNEL assay
were macrophages or neurons or possibly oligodendrocytes
(Fig. 1).
While this article was under revision, Schlitt et al. (2003)
reported that apoptotic T cells and macrophages were de-
tected in the spinal cord of SJL mice infected with the BeAn
strain of TMEV at 31 to 99 days p.i. Demyelinating disease
is observed during this period in the spinal cord of mice
infected with the BeAn strain of TMEV. The DA strain of
TMEV induces clearly two phases of the disease, early
acute disease (gray matter disease) followed by late chronic
demyelinating disease, while the encephalitic stage of the
disease is heavily attenuated in mice infected with the BeAn
strain of TMEV (reviewed by Dal Canto et al., 1996; Mon-
teyne et al., 1997; Oleszak et al., in press; Tsunoda and
Fujinami, 1996). Although both BeAn and DA induce
chronic demyelinating disease, BeAn-infected mice develop
early clear clinical signs of demyelinating disease, such as
waddling gait and hind leg paralysis, at 50 days p.i. (Iwa-
hashi et al., 1999), while DA-infected mice develop such
signs much later, at 140–180 days p.i. Mononuclear infil-
trates in mice infected with the BeAn strain begin to resolve
at about 150 days p.i. (Iwahashi et al., 1999), whereas we
have observed dense mononuclear infiltrates in the CNS of
mice infected with the DA strain as late as 270 days p.i.
These differences in the level of apoptosis of mononuclear
cells infiltrating the CNS of mice infected with the BeAn or
the DA strain may be due to (i) different kinetics of the
disease induced by these strains; or (ii) the dose of the viral
inoculum, which with the BeAn strain used by Schlitt et al.
(2003), was 10-fold-higher than that of the DA strain we
routinely used (Oleszak et al., 1997). Thus apoptotic death
of mononuclear cells is observed predominantly during
Fig. 8. Expression of Bcl-2 on double-positive CD3/Fas T cells infiltrating
the CNS of TMEV-infected mice (three-color analysis). Mononuclear cells
were first labeled with PerCP-conjugated anti-CD3 mAb, followed by anti-Fas
mAb. CD3/Fas double-positive cells were fixed, permeabilized, and la-
beled with FITC-conjugated anti-Bcl-2 mAb and were analyzed by flow
cytometry as described under Materials and methods. Isotype control antibody
staining is shown in the upper right quadrant of the figure.
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early acute disease in the CNS of mice infected with the DA
strain, but mostly during chronic demyelinating disease in
mice infected with the BeAn strain. Also iNOS expression
in the CNS of mice infected with the DA strain is also
different than that of mice infected with the BeAn strain
(Oleszak et al., 1997, 2003; Iwahashi et al., 1999).
Elimination of infiltrating T cells from the CNS by
apoptosis was associated with upregulation of the expres-
sion of Fas and FasL on T cells and downregulation of the
expression of the major antiapoptotic gene Bcl-2. Less than
1.3% of CD3 T cells expressed Bcl-2 during early acute
disease. Upregulation of Fas and FasL expression was lim-
ited to CNS infiltrating cells, since T cells in the spleen of
TMEV-infected mice expressed only low levels of Fas and
FasL. Recruitment of CD3 T cells into the CNS of TMEV-
infected SJL mice during both early acute disease and late
chronic demyelinating disease appears to be associated with
upregulation of the Fas/FasL molecules and T cell activa-
tion, which may be antigen-induced. These T cells may be
activated in the periphery, in response to antigen, before
crossing into the CNS; they may upregulate the expression
of Fas/FasL because of the activation. Alternatively, these
cells may become activated in the CNS. It has been reported
that mouse brain cerebrovascular endothelial cells could be
infected by TMEV (Welsh et al., 1995). These endothelial
cells may act as antigen-presenting cells and may be respon-
sible for the activation of infiltrating T cells. Expression of
Fas and FasL on CD3T cells and virtual absence of Bcl-2
on these cells during early acute disease may account for the
efficient elimination by AICD of infiltrating T cells from the
CNS of TMEV-infected SJL mice after viral clearance.
These results support the hypothesis that viral clearance in
TMEV-infected SJL mice is followed by downsizing of the
inflammatory response through AICD.
A major difference in the mononuclear infiltrates found
during early acute disease and late chronic demyelinating
disease is on the expression of the major antiapoptotic gene
Bcl-2. T cells and monocytes infiltrating the CNS of
TMEV-infected SJL mice with early acute disease are de-
void of Bcl-2-positive cells. It appears that these infiltrating
T cells either downregulate their expression of Bcl-2, or that
the only T cells capable of infiltrating the CNS are those
which express minimal levels of Bcl-2. In contrast, during
late chronic demyelinating disease, infiltrating T cells are
strongly Bcl-2-positive and they are essentially devoid of
apoptotic figures.
The expression of Bcl-2 on CD3 T cells in spleens from
mock-infected SJL mice were substantially higher (11 vs
1%; Table 1) than that on T cells infiltrating the CNS of
TMEV-infected SJL mice at 8 days p.i.. These results sug-
gest that T cells recruited and/or expanded in situ in the
CNS of TMEV-infected mice are under different regulatory
mechanisms than spleen T cells. Upregulation of Fas/FasL
system has also been demonstrated on T cells in the CNS
but not in the spleens of animals with EAE (Bonetti et al.,
1997; McCombe et al., 1996; White et al., 1998). Thus,
during early acute disease, TMEV is cleared (although not
completely) from the CNS of TMEV-infected SJL mice by
T cells that in turn are eliminated from the CNS by AICD.
Although expression of Fas and FasL on T cells in the
CNS suggests that these T cells are undergoing apoptotic
cell death transduced by Fas, we cannot exclude the fact that
cell death is transduced by TNFR. We have previously
reported high levels of TNF- transcripts in the CNS of
TMEV-infected SJL mice (Chang et al., 2000). The down-
sizing of inflammatory, virus-specific T cells by AICD is
obligatory for the host to return to homeostasis. Presumably,
some T cells survive and enter the memory pool (reviewed
by Ahmed and Gray, 1996; Swain et al., 1996). Elimination
of autoreactive T cells through the Fas/FasL pathway
(AICD) from the CNS has also been described in animals
with EAE (McCombe et al. 1996; Waldner et al. 1997;
White et al. 1998). Although a similar level of apoptosis
within inflammatory infiltrates has been observed in the
CNS of TMEV-infected SJL and B6 mice, only the latter
cleared the virus completely. In contrast to B6 mice,
TMEV-infected SJL mice develop late chronic demyelinat-
ing disease associated with fulminate inflammation in
perivascular spaces, meninges, and parenchyma. It has been
described previously that the virus persists at a low level in
the CNS of SJL mice (Kim and Palma, 1999; Monteyne et
al. 1997; Tsunoda and Fujinami, 1996). TMEV antigens and
RNA genome have been detected in macrophages, astro-
cytes, and oligodendrocytes (Brahic et al., 1991; Kim and
Palma, 1999; Lipton, 1975; Oleszak et al., 1995; Rodriguez
et al, 1987). In contrast to early acute disease, we have
detected only rare apoptotic T cells infiltrating the spinal
cord of TMEV-infected SJL mice during late chronic de-
myelinating disease. However, Fas and FasL were ex-
pressed on T cells in the CNS during both early acute and
late chronic demyelinating disease. Lack of apoptosis of
Fas T cells in the CNS during late chronic demyelinating
disease may be explained by the expression of the antiapop-
totic Bcl-2. Indeed, high levels of expression of Bcl-2 have
been found on T cells in the CNS at 40, 107, and 170 days
p.i. (Fig. 7). This is in contrast with early acute disease,
where Bcl-2 was virtually absent on T cells infiltrating the
CNS of TMEV-infected mice (Figs. 6 and 7A). Bcl-2 pro-
teins are found on both naive and memory cells and they
provide survival stimuli (Akbar and Salmon, 1997; Akbar et
al., 1994; Chao and Korsmeyer, 1998; Grayson et al., 2000).
During late chronic demyelinating disease certain T cells
that have survived AICD formed a pool of memory T cells
(unpublished observations B.E. Hoffman, J.R. Chang, C.D.
Platsoucas, E.L. Oleszak). However, the specificity of most
T cells that accumulate in the CNS is not known. T cell
proliferative responses to viral epitopes of BeAn and DA
strains of TMEV have been shown during late chronic
demyelinating disease (Katz-Levy et al., 2000; Kim et al.,
1999; Kang et al., 2002). These were followed by T cell
responses to a number of autoantigens, such as proteolipid
(PLP) and myelin oligodendrocyte protein (MOG) (Katz-
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Levy et al., 2000). The de novo generated responses to
sequestered autoantigens secondary to TMEV-induced T
cell responses have been thought to be responsible for the
propagation of demyelinating disease. The phenomenon has
been designated as “epitope spreading” (Sercarz, 2000;
Voskuhl et al., 1996; Yu et al., 1996). Whether Bcl-2 is
expressed on long-term memory T cells continuously stim-
ulated with viral antigen(s) during persistent infection or on
T cells specific for neoantigens generated in the process of
epitope spreading remains to be established. Despite Fas
and FasL expression on T cells infiltrating the CNS during
late chronic demyelinating disease, they do not undergo
apoptotic cell death. Bcl-2 may prevent transduction of
apoptosis by Fas. The mechanism of interference by Bcl-2
in the CD95 signaling pathway is subject to intensive stud-
ies. It has been suggested that Bcl-2 effectively blocks
activation of caspases triggered by CD95 signaling and that
it blocks apoptosis only in so-called Type II cells (Scaffidi
et al., 1999; Strasser et al., 1995). In these cells apoptogenic
activity depends on mitochondria, while in Type I cells,
CD95 ligation triggers large amounts of active caspase 8
formed at DISC, followed by direct cleavage of caspase 3.
Type I cells are less dependent on apoptogenic activity of
mitochondria and overexpression of Bcl-2 in them does not
block apoptosis. Thus T cells present in the CNS of TMEV-
infected mice during late chronic demyelinating disease
resemble typical Type II cells, such as in the case of hepa-
tocytes. A Bcl-2 transgene expressed in hepatocytes pro-
tects mice from anti-CD95 antibody-induced apoptosis (La-
cronique et al., 1996).
An important question is why the expression of Bcl-2 on
T cells infiltrating the CNS of TMEV-infected mice is
substantially increased during late chronic demyelinating
disease versus early acute disease. Cytokine(s) may play a
role in upregulating Bcl-2. One of these cytokines is IL-2
(Refaeli et al., 1998; Van Parijs et al., 1999). It has been
demonstrated that the removal of IL-2 from in vitro acti-
vated T cells reduces Bcl-2 expression and triggers apopto-
sis (Refaeli et al., 1998; Van Parijs et al., 1999). On the
other hand, addition of exogenous IL-2 upregulates Bcl-2
expression and prevents apoptosis (Van Parijs et al., 1999).
However, Fas-mediated AICD is potentiated by IL-2, which
suggests that IL-2 has a dual function: it may promote
apoptosis, or it could be a survival factor for the cells in
question (Blattman et al., 2003). Recently, it has been re-
vealed that the distinct effect of IL-2 on T cells is induced
through a particular IL-2R-chain signaling motif. IL-2
promotes T cell proliferation, FasL expression on T cells,
and AICD by activation of Stat5 pathway (Van Parijs et al.,
1999; Lin and Leonard, 2000). In contrast, IL-2 can increase
the expression of Bcl-2, a survival molecule, by activating
Akt (Ahmed et al., 1997; Van Parijs et al., 1999). Other
cytokines, such as IL-4, IL-7, and IL-15, which signal via
IL-2R-chain, may also prevent apoptosis of activated T
cells by induction of Bcl-2 gene (Ahmed et al., 1997; Akbar
et al, 1994; Dai et al., 1999; Li et al., 2000; Vella et al.,
1998). We have previously reported the induction of high
levels of IL-2 (both transcripts and protein) before the onset
of the demyelinating disease at 25–39 days p.i. coinciting
with a new wave of T cells of unknown specificity that
infiltrate the spinal cord of TMEV-infected SJL mice
(Chang et al., 2000). These relatively high levels of IL-2
could trigger the induction of Bcl-2, which begins to be
expressed on infiltrating T cells approximately at the same
time as IL-2. Furthermore, IL-4, another cytokine that can
induce Bcl-2 in T cells, is expressed in the CNS during late
chronic demyelinating disease in TMEV-infected SJL mice
(Chang et al., 2000). Much lower levels of IL-2 (Chang et
al., 2000) may be sufficient to support antigen-driven clonal
expansion of T cells in the CNS in response to the virus, as
well as Fas/FasL expression, during early acute disease.
However, after viral clearance, these T cells are induced to
undergo apoptosis by a mechanism(s) that very likely in-
volves AICD.
Our results are in agreement with recent studies in pa-
tients with MS. These studies revealed remarkably few
apoptotic T cells in the brains of these patients with massive
perivascular infiltrates in acute lesions (Dowling et al.,
1997). Recently, impaired apoptotic deletion of myelin ba-
sic protein-reactive T cells has also been described in MS
patients (Ichikawa et al., 1999; Zang et al., 1999). In gen-
eral, T lymphocytes from the peripheral blood of patients
with MS are less susceptible to AICD through numerous
impairments of the apoptotic pathways (Sharief and Semra,
2001; Sharief et al., 2002; Waiczies et al., 2002). In a
separate study, the expression of Bcl-2 and T lymphocytes
has been examined in MS plaques. High levels of Bcl-2
have been found in T cells infiltrating the CNS of patients
with chronic progressive MS (Zettl et al., 1998). The mech-
anism(s) leading to T cell persistence in the CNS is not
known. However, similarities between low levels of apop-
tosis of T cells in the CNS of TMEV-infected animals
during late chronic demyelinating disease and T cells in the
CNS of patients with MS are striking. These similarities
suggest the existence of a common pathway of T cell reg-
ulation during inflammatory demyelinating disease in both
mouse and human.
Materials and methods
Virus
The wild-type Daniel strain of TMEV was used in all
experiments. The origin and propagation of this virus has
been previously reported (Oleszak et al., 1988, 1997).
Animals
Five- to-six-week-old female SJL and B6 mice were
purchased from Jackson Laboratory (Bar Harbor, ME).
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Mice were housed in microisolators in a biohazard level II
facility. All manipulations and changes of cages were per-
formed in a biohazard hood. Mice were maintained in ac-
cordance with the standards of the American Association
for Accreditation of Laboratory Animal Care. Mice were
slightly anesthetized with isoflurane and inoculated with
approximately 105 PFU of TMEV in a 20-l volume in the
right cerebral hemisphere. Control, mock-infected animals
were injected with Dulbecco’s modified Eagle’s medium
(DMEM) containing 2% fetal calf serum (FCS) and stan-
dard amounts of penicillin, streptomycin, and glutamine.
Mice were euthanized by the administration of an overdose
of isoflurane, and their spinal cords and brains were imme-
diately removed and placed in 10% buffered formalin. For-
malin-fixed spinal cords and brains were embedded in par-
affin and cut into 5-m-thick sections. Additionally, brain
and spinal cords of TMEV-infected mice were aseptically
removed and homogenized, and viral titer was determined
using plaque assay, as described (Oleszak et al., 1988,
1997).
Antibodies
Phycoerythrin (PE)- or PerCP-conjugated hamster anti-
mouse CD3 monoclonal antibody (mAb), PE-, or PerCP-
conjugated hamster isotypic control mAb, FITC-conjugated
hamster anti-mouse Bcl-2 mAb, and FITC-conjugated ham-
ster isotypic control mAb, biotinylated hamster anti-mouse
CD95 mAb, and biotinylated hamster isotypic control mAb
were used in the immunofluorescence determinations by
flow cytometry described here and were purchased from BD
Pharmingen (San Diego, CA). CD95L cells were deter-
mined in the CNS and spleen of TMEV-infected mice at
227 days p.i., using a PE-conjugated mouse anti-mouse
CD95L mAb (BD Pharmingen). The following polyclonal
antibodies used in the experiments described here were
purchased from Serotec Ltd. (Oxford, UK): purified rabbit
anti-mouse CD95, purified rabbit anti-mouse CD95L, puri-
fied rat anti-human CD3 peptide (which also recognizes
mouse CD3), purified rabbit anti-mouse Bcl-2, and purified
rat anti-F4/80 antigen (macrophage marker). Biotinylated
goat anti-rabbit and streptavidin-conjugated FITC were pur-
chased from Jackson ImmunoResearch Laboratories, Inc.
(West Grove, PA). The DamAb2 monoclonal anti-TMEV
antibody was generously provided by Dr. R. Roos (Univer-
sity of Chicago, IL) (Nitayaphan et al., 1985).
Immunohistochemistry
Apoptotic cells were detected by immunohistochemistry
using a TUNEL kit (Intergen, Purchase, NY). According to
this method terminal deoxynucleotidyl transferase (TdT)
extends the 3 end of DNA with digoxigenin-11-dUTP. The
procedure was carried out in accordance with the manufac-
turer’s recommendations. Tissue sections were developed
with 3,3-diaminobenzidine (DAB) (Vector Laboratories,
Burlingame, CA) and were counterstained with methyl
green (Sigma Chemical Co., St. Louis, MO).
For single labeling, the slides were rehydrated in xylene
and alcohols followed by washing with phosphate-buffered
saline (PBS) or Tris-buffered saline (TBS). Endogenous
peroxidases were blocked by incubation of the slides for 10
min in 3% hydrogen peroxide in methanol. Antigen re-
trieval was performed in 0.1 M citrate buffer (pH 6.0) using
a pressure cooker in a microwave oven for 1.25 min. Tissue
sections used for macrophage marker detection were pre-
treated for 30 min at 37°C with a trypsin solution (1 mg/ml,
pH 7.8) (Sigma). Specific antigens were detected by the
immunoperoxidase technique (Vectastain Elite ABC kit;
Vector Laboratories). DAB was used as the substrate. Tis-
sue sections were counterstained with Mayer’s hematoxylin
(Sigma).
Double labeling for TUNEL CD3 cells was carried
out by sequential staining for TUNEL cells (DAB sub-
strate) followed by staining with the anti-CD3 peptide
antibody by an immunohistochemistry (ABC kit; Vector
Laboratories) with the final peroxidase complex being de-
veloped with Vector VIP substrate (Vector Laboratories)
according to the manufacturer’s instruction and without
counterstaining.
Virus-infected cells were stained using the DamAb2
mouse anti-TMEV MAb as described (Hierck et al., 1994).
Anti-TMEV antibody was incubated with 1:200 dilution of
biotinylated anti-mouse secondary antibody (Vectastain
Elite Anti-Mouse ABC kit) overnight at 4°C. To remove
any excess of secondary antibody, 0.1% (v/v) normal mouse
serum was added to the cocktail and incubated for 1 h.
Tissue sections were incubated with blocking solution (Vec-
tastain Elite Anti-Mouse ABC kit) for 30 min followed by
1 h incubation with precomplexed primary/secondary anti-
body mixture. Slides were washed twice in PBS. The sec-
tions were then incubated with ABC solution for 30 min.
Slides were developed using DAB and counterstained with
Mayer’s hematoxylin.
Isolation of mononuclear cells from CNS or spleen
Mononuclear cells were isolated from the CNS as de-
scribed (Clatch et al., 1990). Briefly, virus-infected or
mock-infected mice were anesthetized with isoflurane and
perfused with approximately 30 ml of sterile PBS through
the left ventricle. To obtain a single-cell suspension the
CNS tissue or spleens were dissociated through a no. 100
stainless steel mesh. After letting the connective tissue de-
bris settle for 1 min, the supernatant was centrifuged at 300
g for 7 min at room temperature. The supernatant was
discarded and the cells (isolated from four spinal cords or
two brains which were pooled together) were resuspended
in 3 ml of 68% Percoll (Sigma) and overlaid with 30%
Percoll (Sigma), as described (Clatch et al., 1990). The cells
were centrifuged at 400 g for 25 min at room temperature.
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Cells at the interphase were collected and washed twice
with PBS.
Flow cytometry
Double labeling for determination of Fas/CD3 and
FasL/CD3 cells was carried out using single-cell sus-
pensions of mononuclear cells isolated from the CNS or
spleens of mice resuspended in DMEM supplemented with
2% FCS. Cells (1 105 to 1 106 per tube) were incubated
with PE-labeled hamster anti-CD3 mAb (or control PE-
labeled hamster isotypic control mAb) for 1 h on ice and
were washed twice with cold PBS. In most experiments Fc
Block (0.5 g/106 cells) (BD Pharmingen) was added to the
cell suspension to prevent nonspecific binding of antibodies
and the cells were incubated for 5 min at room temperature
before the addition of primary antibodies. The cells were
then incubated with either rabbit anti-mouse CD95 antibody
or with rabbit anti-CD95L antibody for 1 h on ice and
washed with PBS. Purified rabbit IgG was used for controls.
Subsequently cells were incubated with the secondary bio-
tinylated goat anti-rabbit antibody for 1 h on ice and washed
again twice in PBS. Streptavidin-FITC was added to each
tube and after 30 min of incubation cells were washed twice.
After 1 h incubation on ice, cells were washed twice and
fixed in 1% buffered paraformaldehyde (BPFA).
Three-color analysis was used for the simultaneous de-
tection of surface (Fas and CD3) and intracellular antigens
(Bcl-2). Mononuclear cells isolated from the CNS or from
spleens of TMEV-infected mice were first labeled with
PerCP-conjugated anti-CD3 mAb (or PerCP-conjugated
control isotypic mAb) for 1 h on ice. Cells were washed
with PBS and subsequently labeled with biotinylated anti-
Fas mAb for 30 min on ice. After removal of unbound
antibodies by two washes with PBS, cells were incubated
with streptavidin–PE complex for an additional 30 min.
CD3/Fas double-labeled cells were fixed with 1% of BPFA
for 30 min on ice and permeabilized with 0.2% saponin
solution in PBS for 30 min at room temperature. FITC-
conjugated anti-Bcl-2 or FITC-conjugated control isotypic
mAb was added to double-labeled cells and incubated for
1 h at RT. Cells were washed in 0.2% saponin solution in
PBS followed by several washings with PBS. Final pellets
were resuspended in 1% PFA. All samples were analyzed
using an EPICS-XL flow cytometer (Coulter Corp., Hialea,
FL).
In certain experiments cells were double labeled with
PerCP-conjugated anti-CD3 and FITC-conjugated anti-
Bcl-2 as described above.
Apoptosis TUNEL analysis ex vivo
Apoptosis of CD3 T cells was evaluated by the FITC
labeling of the 3 end of DNA by terminal deoxynucleotidyl
transferase assay using the Apo-Direct kit from Pharmingen.
Briefly, mononuclear cells were isolated from the CNS as
described above and were first labeled with PerCP-conjugated
anti-CD3 mAb (or with PerCP-conjugated control isotypic
mAb). After 1 h incubation on ice the cells were washed twice
with PBS and samples were each resuspended in 0.5 ml of
PBS. Cells were fixed by adding 5 ml of 1% of ice-cold 70%
ethanol per tube and the tubes were kept for 30 min at 20°C.
Cells were washed twice, and TdT and FITC-dUTP were
added in reaction buffer and incubated at 37°C for 60 min. TdT
was omitted from control samples. Samples were analyzed by
flow cytometry as described above.
Statistical analysis
Flow cytometry data were analyzed as the proportion,
q2/q1q2, under each set of experimental conditions, using
a logit transformation in a generalized linear model with the
binomial distribution (PROC GENMOD, SAS Institute,
Cary, NC). Treatment comparisons were adjusted using the
Bonferroni–Holm step-down procedure for multiple com-
parisons. Differences were considered significant if the ad-
justed P value was 0.05.
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